HRS-8427

Small molecule

Phase 3Mechanism not established
Phase 3complete

Evidence outlook · registrational

Complicated Urinary Tract Infection: registrational trials complete

No completed mid-stage readout is on record. Its registrational studies have completed. Check News and the registry record for topline outcomes.

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.

Phase 3 (1)
Complicated Urinary Tract Infection
NCT06569056 · Jiangsu HengRui Medicine Co., Ltd.
2024-09-25 – 2026-09-01 · Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP)
What this study did
Phase 2 (2)
Complicated Urinary Tract Infection
NCT06144060 · Jiangsu HengRui Medicine Co., Ltd.
2023-12 – 2024-07 · Patients With Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP)
What this study did
Other / comorbidity
NCT06841731 · Jiangsu HengRui Medicine Co., Ltd.
2025-04-10 – 2026-10-09 · Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP)
What this study did
Phase 1 (4)
Other / comorbidity
NCT07073157 · Jiangsu HengRui Medicine Co., Ltd.
2025-07-15 – 2025-08-15 · Health Volunteer
What this study did
NCT07049107 · Jiangsu HengRui Medicine Co., Ltd.
2025-06-23 – 2025-07-21 · Health Volunteer
What this study did
NCT07049562 · Jiangsu HengRui Medicine Co., Ltd.
2025-05-21 – 2025-06-18 · Healthy Cninese Adult Male
What this study did
NCT07070375 · Jiangsu HengRui Medicine Co., Ltd.
2023-04-19 – 2023-08-23 · Gram-negative Bacterial Infections
What this study did

Competitive landscape

No competitors sharing a mechanism or indication in the current universe.

Upcoming events

No upcoming readouts on record for this asset.